MTOR and cancer: As mTOR inhibitors in monotherapy have been shown to be effective in several types of cancer, numerous clinical trials have explored the potential of mTOR inhibitors in combination with other molecularly-targeted or chemotherapeutic agents to reverse drug resistance [47–50].